Biosyntech Top Insiders
Biosyntech employs about 6 people. The company is managed by 4 executives with a total tenure of roughly 14 years, averaging almost 3.0 years of service per executive, having 1.5 employees per reported executive. Assessment of Biosyntech's management performance can provide insight into the firm performance.
| Amine Selmani Insider Founder Advisor |
| Alberto MD Insider Director Affairs |
Biosyntech |
Biosyntech Management Team Effectiveness
The company has return on total asset (ROA) of (0.5193) % which means that it has lost $0.5193 on every $100 spent on assets. This is way below average. Biosyntech's management efficiency ratios could be used to measure how well Biosyntech manages its routine affairs as well as how well it operates its assets and liabilities.Biosyntech Workforce Comparison
Biosyntech is rated third in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 396. Biosyntech claims roughly 6.0 in number of employees contributing just under 2% to equities under Health Care industry.
Biosyntech Notable Stakeholders
A Biosyntech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biosyntech often face trade-offs trying to please all of them. Biosyntech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biosyntech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Amine Selmani | Founder Advisor | Profile | |
| Alberto MD | Director Affairs | Profile | |
| Lucie Duval | Controller | Profile | |
| Catherine CA | Chief Officer | Profile |
About Biosyntech Management Performance
The success or failure of an entity such as Biosyntech often depends on how effective the management is. Biosyntech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biosyntech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biosyntech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. On May 12, 2010, Biosyntech Inc. filed for administration under the Bankruptcy and Insolvency Act. BIOSYNTECH INC is traded on PNK Exchange in the United States.
Biosyntech Workforce Analysis
Traditionally, organizations such as Biosyntech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biosyntech within its industry.Biosyntech Manpower Efficiency
Return on Biosyntech Manpower
| Revenue Per Employee | 843 | |
| Revenue Per Executive | 1.3K | |
| Net Loss Per Employee | 2.2M | |
| Net Loss Per Executive | 3.2M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Biosyntech Pink Sheet
If you are still planning to invest in Biosyntech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biosyntech's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |